Kati Patang Lifestyle Limited Concludes Extraordinary Genera...
06 Apr 2026
Rekvina Laboratories Limited has officially notified BSE Limited that it is claiming exemption from submitting the Annual Secretarial Compliance Report for the financial year ended 31st March, 2026. The communication, dated 06.04.2026, was addressed to the Department of Corporate Services at BSE.
Regulatory Exemption Details
The company has invoked Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which provides specific exemptions for smaller listed entities. Under this regulation, companies meeting certain financial criteria are exempt from various corporate governance provisions.
Exemption Parameter: Threshold Limit Paid-up Equity Share Capital: Not exceeding Rs 10 crores Net Worth: Not exceeding Rs 25 crores Assessment Period: Last day of previous financial year
Scope of Exemptions
The exemption covers extensive corporate governance provisions under SEBI regulations. The company is relieved from compliance with multiple regulations and specific clauses that typically apply to larger listed entities.
Exempt Regulations:
Regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 26A, 27
Clauses (b) to (i) and (t) of sub-regulation (2) of regulation 46
Para C, D and E of Schedule V
Company Information
Rekvina Laboratories Limited operates under CIN L24231GJ1988PLC01145 with its registered office located at 36, Sampatrao Colony, Next to Royal Hotel, Alkapuri, Baroda. The notification was signed by Director Surbhit Mukesh Shah (DIN: 01993300), confirming the company's position regarding the non-applicability of the Annual Secretarial Compliance Report requirement.
The company has requested BSE to acknowledge this exemption claim and take note of its regulatory status for the financial year 2026.
Rekvina Laboratories Limited has submitted its quarterly compliance certificate to BSE Limited under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the fourth quarter of fiscal year 2026. The certificate, dated 06.04.2026, covers the period from 1st January, 2026 to 31st March, 2026.
Regulatory Compliance Filing
The compliance certificate was signed by Shah Surbhit Mukeshbhai, Director of Rekvina Laboratories Limited (DIN: 01993300), and submitted to the Department of Corporate Services at BSE Limited. The company trades under scrip code 526075 on the exchange.
Filing Details: Information Period Covered: 1st January, 2026 to 31st March, 2026 Submission Date: 06.04.2026 Scrip Code: 526075 Director: Shah Surbhit Mukeshbhai DIN: 01993300
Registrar and Transfer Agent Confirmation
M/s. Purva Sharegistry India Pvt. Ltd, serving as the company's Registrar and Share Transfer Agent, provided the compliance certificate. The agency, registered with SEBI under registration number INR000001112 as Category 1 Registrars to IPO & Share Transfer Agents, confirmed adherence to regulatory requirements for dematerialisation processes.
Ms. Deepali Gaonkar, Compliance Officer at Purva Sharegistry, certified that all securities received from depository participants during the quarter were properly processed and confirmed to depositories within prescribed timelines. The certificate also confirms that security certificates received for dematerialisation were mutilated and cancelled after due verification.
Dematerialisation Activity Summary
The quarterly report reveals no dematerialisation activity during the Q4FY26 period. The detailed breakdown shows:
Activity Parameter: Status Folio Numbers: NIL Shareholder Names: NIL Certificate Numbers: NIL Share Quantities: NIL Dematerialisation Dates: NIL
This indicates that no shareholders opted to convert their physical share certificates to electronic form during the January-March 2026 quarter. The 'NIL' entries across all categories in the dematerialisation details table confirm zero activity in this regard.
Regulatory Framework
The filing ensures compliance with SEBI's quarterly reporting requirements under the Depositories and Participants Regulations, 2018. These regulations mandate that companies submit confirmation certificates regarding their dematerialisation activities, ensuring transparency in the conversion process from physical to electronic securities. The timely submission demonstrates Rekvina Laboratories' commitment to regulatory compliance and corporate governance standards.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.
